Home › Asset managers › Compare 2024-2025 › TIAA vs Lincoln Financial
TIAA 2024-2025 · Lincoln Financial 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 72,648 | 63,965 | 4,302 | 4,381 | 93.7% | 91.6% |
| Board proposals | 59,220 | 51,622 | 3,891 | 3,707 | 93.0% | 90.8% |
| E&S shareholder proposals | 257 | 127 | 25 | 105 | 83.6% | 73.1% |
| Other items | 13,171 | 12,216 | 386 | 569 | 96.9% | 95.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
3,891 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | TIAA | Lincoln Financial |
|---|---|---|---|---|---|---|
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Lock-Up Period Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Method and Time of Issuance Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Number of Shares to be Issued Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Place of Listing Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Preliminary Proposal of the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Pricing Benchmark Date, Issue Price and Pricing Principle Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Report on Use of Proceeds from Previous Fund-Raising Activities of the Company Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Satisfaction of the Company of the Requirements for the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Specific Mandate Related to the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Target Subscribers and Method of Subscription Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Undertakings to be Made by the Relevant Entities in Respect of the Measures on the Dilution of the Company's Current Return by the Proposed Issuance of A Shares to Specific Target Subscribers Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COSCO SHIPPING ENERGY TRANSPORTATION CO. LTD. | April 11, 2025 | Approve Validity Period of the Resolution Prior to the Issuance Capital Structure |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| COUCHBASE INC. | May 29, 2025 | Election of Class I Directors: Lynn M. Christensen Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 2 funds |
| COWELL E HOLDINGS INC. | May 29, 2025 | Elect Meng Yan as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CRANSWICK PLC | July 29, 2024 | Approve Remuneration Policy Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Election of Directors: Glenda J. Flanagan Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 2 funds |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Election of Directors: Scott J. Vassalluzzo Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 2 funds |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Election of Directors: Thomas N. Tryforos Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 2 funds |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Election of Directors: Vinayak R. Hegde Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 2 funds |
| CRICUT INC. | May 28, 2025 | Election of Directors: Ashish Arora Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 1 fund |
| CRICUT INC. | May 28, 2025 | Election of Directors: Billie Williamson Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 1 fund |
| CRICUT INC. | May 28, 2025 | Election of Directors: Melissa Reiff Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 1 fund |
| CRICUT INC. | May 28, 2025 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| CRONOS GROUP INC | July 19, 2024 | ADOPTION OF AN ADVISORY (NON-BINDING) RESOLUTION TO APPROVE THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT DATED APRIL 26, 2024 Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CRONOS GROUP INC. | July 19, 2024 | Election of Directors: Dominik Meier Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | July 19, 2024 | Election of Directors: Kamran Khan Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | July 19, 2024 | Election of Directors: Michael Gorenstein Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Dominik Meier Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Elizabeth Seegar Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: James Rudyk Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Jason Adler Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Kamran Khan Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Michael Gorenstein Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| CRONOS GROUP INC. | June 20, 2025 | Election of Directors: Murray Garnick Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 1 fund |
| CROSS COUNTRY HEALTHCARE INC. | February 28, 2025 | To approve on an advisory (non-binding) basis the compensation that may be paid or become payable to Cross Country's named executive officers that is based on or otherwise relates to the merger. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CROWDSTRIKE HOLDINGS INC. | June 18, 2025 | To elect CrowdStrike's nominees Cary J. Davis, George Kurtz and Laura J. Schumacher to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Cary J. Davis Director Elections |
Board | For | FOR 10 funds |
WITHHOLD 2 funds |
| CRYOPORT INC. | June 6, 2025 | To elect six directors: Linda Baddour Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 5 funds |
| CRYOPORT INC. | June 6, 2025 | To elect six directors: Ramkumar Mandalam, PhD Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 5 funds |
| CRYOPORT INC. | June 6, 2025 | To elect six directors: Robert Hariri, MD, PhD Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 5 funds |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Attribution of Profit and Loss During the Transition Period Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Audit Report, Pro Forma Review Report and Valuation Report in Relation to the Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds Capital Structure |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds Capital Structure |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) Extraordinary Transactions |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CTBC FINANCIAL HOLDING CO. LTD. | June 13, 2025 | Approve Issuance of Restricted Stocks Compensation |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| CTO REALTY GROWTH INC. | June 18, 2025 | Election of Directors: Mr. Christopher J. Drew Director Elections |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| CTO REALTY GROWTH INC. | June 18, 2025 | Election of Directors: Mr. Christopher W. Haga Director Elections |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| CTO REALTY GROWTH INC. | June 18, 2025 | Election of Directors: Mr. R. Blakeslee Gable Director Elections |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| CTS EVENTIM AG & CO. KGAA | May 21, 2025 | Approve Remuneration Policy Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| CTS EVENTIM AG & CO. KGAA | May 21, 2025 | Approve Remuneration Report Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| CUBESMART | May 20, 2025 | Election of Trustees: Piero Bussani Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 5 funds |
| CULLEN/FROST BANKERS INC. | April 30, 2025 | To provide nonbinding approval of executive compensation; Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 4 funds |
| CURTISS-WRIGHT CORP. | May 8, 2025 | Election of Directors: Dean M. Flatt Director Elections |
Board | For | WITHHOLD 7 funds |
FOR 8 funds |
| CUSTOMERS BANCORP INC. | May 27, 2025 | Election of Directors: Andrea R. Allon Director Elections |
Board | For | AGAINST 9 funds |
FOR 5 funds |
| CUSTOMERS BANCORP INC. | May 27, 2025 | Election of Directors: Daniel K. Rothermel Director Elections |
Board | For | AGAINST 9 funds |
FOR 5 funds |
| CVC CAPITAL PARTNERS PLC | May 20, 2025 | Approve Remuneration Report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CVC CAPITAL PARTNERS PLC | May 20, 2025 | Authorise Audit Committee to Fix Remuneration of Auditors Audit-related |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CVC CAPITAL PARTNERS PLC | May 20, 2025 | Elect Rolly van Rappard as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CVC CAPITAL PARTNERS PLC | May 20, 2025 | Ratify Deloitte LLP as Auditors Audit-related |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CVS GROUP PLC | November 20, 2024 | Approve Remuneration Report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CYBERAGENT INC. | December 13, 2024 | Elect Director Fujita, Susumu Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CYBOZU INC. | March 30, 2025 | Appoint Statutory Auditor Ogawa, Yoshitatsu Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| D'IETEREN GROUP | December 6, 2024 | Approve Dividends Capital Structure |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| D'IETEREN GROUP | June 5, 2025 | Approve Remuneration Policy Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| D'IETEREN GROUP | June 5, 2025 | Approve Remuneration Report Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| D'IETEREN GROUP | June 5, 2025 | Reelect HECHO SRL, Represented by Hugo De Stoop, as Independent Director Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| DAH SING FINANCIAL HOLDINGS LTD. | May 30, 2025 | Elect Mariana Suk-Fun Ngan as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| DAI-DAN CO. LTD. | June 27, 2025 | Elect Director Fujisawa, Ichiro Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| DAI-DAN CO. LTD. | June 27, 2025 | Elect Director Yamanaka, Yasuhiro Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| DAIDO STEEL CO. LTD. | June 25, 2025 | Elect Director Hiramitsu, Noriyuki Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| DAIDO STEEL CO. LTD. | June 25, 2025 | Elect Director Ishiguro, Takeshi Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
← Previous Page 10 of 39 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.